Related Experiment Video
Updated: Jul 16, 2025
Mass Spectrometry and Luminogenic-based Approaches to Characterize Phase I Metabolic Competency of In Vitro Cell Cultures
Published on: March 28, 2017
Screening in serum-derived medium reveals differential response to compounds targeting metabolism
Keene L Abbott1, Ahmed Ali2, Dominick Casalena3
1Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA; Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02139, USA; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.
Abstract:
A challenge for screening new anticancer drugs is that efficacy in cell culture models is not always predictive of efficacy in patients. One limitation of standard cell culture is a reliance on non-physiological nutrient levels, which can influence cell metabolism and drug sensitivity. A general assessment of how physiological nutrients affect cancer cell response to small molecule therapies is lacking. To address this, we developed a serum-derived culture medium that supports the proliferation of diverse cancer cell lines and is amenable to high-throughput screening. We screened several small molecule libraries and found that compounds targeting metabolic enzymes were differentially effective in standard compared to serum-derived medium. We exploited the differences in nutrient levels between each medium to understand why medium conditions affected the response of cells to some compounds, illustrating how this approach can be used to screen potential therapeutics and understand how their efficacy is modified by available nutrients.
Insights
Standard cell culture models do not always predict anticancer drug efficacy in patients. Physiological nutrient levels in a novel serum-derived medium reveal differential drug responses, improving therapeutic screening.
Area of Science:
- Cancer Research
- Drug Discovery
- Cell Biology
- Metabolic Engineering
Background:
- Efficacy of novel anticancer drugs in cell culture often fails to translate to patient outcomes.
- Standard cell culture media utilize non-physiological nutrient concentrations, impacting cancer cell metabolism and drug sensitivity.
- A comprehensive understanding of how physiological nutrient levels influence cancer cell responses to small molecule therapies is needed.
Purpose of the Study:
- To develop a serum-derived culture medium supporting diverse cancer cell line proliferation for high-throughput screening.
- To assess the impact of physiological nutrient levels on cancer cell response to small molecule therapies.
- To elucidate the mechanisms by which nutrient availability modifies therapeutic efficacy.
Main Methods:
- Development of a serum-derived culture medium mimicking physiological nutrient conditions.
- High-throughput screening of small molecule libraries against diverse cancer cell lines in standard and serum-derived media.
- Comparative analysis of drug efficacy and cell response across different nutrient environments.
Main Results:
- Compounds targeting metabolic enzymes exhibited differential efficacy between standard and serum-derived media.
- Nutrient composition of the culture medium significantly influenced cancer cell sensitivity to specific small molecule inhibitors.
- The study successfully identified specific nutrient-dependent drug responses.
Conclusions:
- A serum-derived culture medium provides a more physiologically relevant platform for anticancer drug screening.
- Nutrient microenvironment is a critical factor modulating the efficacy of metabolic enzyme-targeting anticancer therapies.
- This approach enhances the predictive power of preclinical drug screening and aids in understanding drug-nutrient interactions.
More Related Videos
10:38Simultaneous Quantification of Selected Kynurenines Analyzed by Liquid Chromatography-Mass Spectrometry in Medium Collected from Cancer Cell Cultures
Published on: May 9, 2020
11:39Extraction of Aqueous Metabolites from Cultured Adherent Cells for Metabolomic Analysis by Capillary Electrophoresis-Mass Spectrometry
Published on: June 9, 2019
Related Concept Videos
01:19Factors Affecting Drug Biotransformation: Biological
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
01:27Microbial Growth Media